CXCR4 and neoplasm: In this study, the novel synthesized probe RENPs can be specifically enriched in tumor cells with highly expressed CXCR4, especially in TNBC.[26] Many CXCR4 targeted drugs such as monoclonal antibodies, peptides, and small molecular inhibitors have been developed.